Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2487)	4/27/2009 12:46:18 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

But NVAX is the one that has benefited the most from the flu epidemic news.<g> It is up 93.66% on volume of 31,809,000 > 10x its ADV. :>) bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2487)	4/28/2009 2:39:02 PM
From: Jibacoa	Respond to of 3722

HEB is down 19.75% with volume now above 2,819,800 as the stock tries to close yesterday's UG.<g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2487)	8/7/2009 5:58:40 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

AVII closed up 9.09% with volume more than 300Ks over its ADV, but is having some profit taking AHs. It is scheduled to report its 2ndQ results on Monday when the market opens Th stock has been on a recent UT since Apr 27 when it was able to close back above $1 bigcharts.marketwatch.com Support remains at $2 and nearest resistance at $2.50 and then at the Jul30 H of $2.73 At the time they reported the 1stQ results in May, they said that they planned to spend $10 or $12M on the cruurent Yr. They had about $25M in cash. I don't know if that included the $5.1M from DTRA for antisense work on the swine flu. The ACTY (analysts' consensus 'target' at Yahoo) is $2.75, but with some good news the stock could get back to the $5 level. <g> bigcharts.marketwatch.com Bernard